NLS Pharmaceutics Ltd.

( )
NLSP After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 0.14%43.980.9%$1331.61m
ABBVAbbVie, Inc. -0.65%106.451.9%$1004.17m
JNJJohnson & Johnson -0.41%163.850.7%$1000.58m
MRKMerck & Co., Inc. 0.07%72.020.7%$853.66m
LLYEli Lilly & Co. -0.77%228.391.1%$608.85m
BMYBristol-Myers Squibb Co. -0.25%60.181.0%$558.20m
AZNAstraZeneca Plc -0.66%58.741.0%$328.11m
NVSNovartis AG -0.28%82.820.2%$164.54m
CRVSCorvus Pharmaceuticals, Inc. -12.19%7.490.7%$151.15m
GSKGlaxoSmithKline Plc 0.54%39.290.2%$132.85m
SNYSanofi 0.54%48.480.2%$123.93m
RPRXRoyalty Pharma Plc -0.93%36.290.1%$116.48m
RGENRepligen Corp. -0.34%313.106.8%$111.78m
VTRSViatris, Inc. -0.23%13.250.0%$107.41m
NVONovo Nordisk A/S -0.86%100.900.1%$105.50m

Company Profile

NLS Pharmaceutics Ltd. engages in the discovery and development of drug therapies to treat rare and complex central nervous systems disorders, including narcolepsy, idiopathic hypersomnia and other rare sleep disorders, and of neurodevelopmental disorders, such as Attention Deficit Hyperactivity Disorder(ADHD). The company was founded by Ronald Hafner and Alexander Zwyer in August 2015 and is headquartered in Stans, Switzerland.